Trends in Use and Perceptions About Triplet Chemotherapy Plus Bevacizumab for Metastatic Colorectal CancerSietske C. van Nassau, Lieke H. J. Simkens, Rob Kessels et al.|JAMA Network Open|2021Cited by 10
423P From clinical trial to bedside: Triplet chemotherapy (FOLFOXIRI-B) in metastatic colorectal cancerGuus M. Bol, Miriam Koopman, Sietske C. van Nassau et al.|Annals of Oncology|2021Cited by 0